Biolexis Therapeutics, Inc. Employee Directory
Biotechnology ResearchUtah, United States11-50 Employees
Biolexis Therapeutics, Inc. is a biotechnology research company based in Lehi, Utah. It develops oral therapies in metabolic medicine, aiming to match the efficacy of injectable treatments while improving tolerability, with designs for convenient daily dosing and fixed-dose combinations. Its work concentrates on advancing treatments for obesity and related metabolic disorders through these oral agents. The company expanded its scope with the creation of Metabolexis, a subsidiary focused on developing oral medicines for obesity and Type 2 diabetes to support human longevity. It participates in industry activities, including presenting data at ObesityWeek 2025. These efforts illustrate its emphasis on non-injectable metabolic therapies within the biotechnology landscape.